Moderna raised its full-year sales outlook after a bigger-than-expected profit

Summary
The drugmaker's 2026 revenue growth forecast is 15% to 25%, up from up to 10%; its year-end cash outlook rose to $8.1 billion to $8.3 billion
Description from Quartz.
Who is covering this
-
Moderna raised its full-year sales outlook after a bigger-than-expected profit
The drugmaker's 2026 revenue growth forecast is 15% to 25%, up from up to 10%; its year-end cash outlook rose to $8.1 billion to $8.3 billion
Comments
Comments need JavaScript.